Introduction
Cabergoline (1) is a natural product-based drug, representing a complex, branched amide of 6-N-allylated 9,10-dihydrolysergic acid (cabergolinic acid) A (Fig. 1) . Primarily acting as a dopaminergic D 2 receptor agonist, cabergoline is most widely used for treatment of hyperprolactinaemic disorders and both early and advanced Parkinson's disease. 1 The structure of cabergoline also encodes for different biogenic amines than dopamine, therefore displaying modest pharmacodynamic properties towards adrenergic and serotonergic receptors.
1
One of the fundamental roles of the pharmaceutical industry is to develop new drugs that are safe, effective and of high quality when they reach the patients. With respect to this, delivering an impurity prole of an active pharmaceutical ingredient (API) is a must for fullling the aforementioned criteria.
2 For the purpose of qualifying and/or quantifying the impurity prole of cabergoline (1) as the API, we have synthesized four known impurities, qualied by European Pharmacopoeia (Ph. Eur.) 3 as impurities A, B, C and D (Fig. 1 ). The genesis of these impurities can be found in the syntheses and other manufacturing process activities of cabergoline (Scheme 1).
4
Since cabergoline (1) , with the maximum weekly dosage of 2.0 mg, falls into low dosing drugs, the threshold for identi-cation and qualication of impurities in API is usually 0.10% and 0.15% of mass, respectively.
2 These limits are low and efficient production processes should not exceed them. Therefore production syntheses are usually neither suitable nor cost effective means to produce impurities for the use of analytics. Oen, new synthesis routes have to be designed to obtain desired impurities and this was also our task. Synthesis routes for Ph. Eur. impurities A, B, C and D of cabergoline (1) were designed and results are presented in this paper.
Results and discussion
9,10-Dihydrolysergic acid (2) was selected as one of the key synthetic intermediates. Although there are several total syntheses of lysergic acid available, through which 9,10-dihydrolysergic acid (2) could be prepared, a-ergocryptine (3) was chosen as starting material. The reason is that a-ergocryptine (3) is biosynthetically produced at our production site and way of preparing 9,10-dihydrolysergic acid (2) from a-ergocryptine (3) is advantageous over total synthesis because it is shorter, easier and more economical. Also, there is a longstanding tradition of ergot alkaloids chemistry within Sandoz company, pioneered by Albert Hofmann.
Starting with a-ergocryptine (3), the double bond between C9-C10 was diastereoselectively hydrogenated and the reduced ergopeptine 4 was cleaved by alkaline hydrolysis to give 9,10-dihydrolysergic acid (2) .
5 To increase solubility of 9,10-dihydrolysergic acid (2) in organic solvents, the corresponding methyl ester 5 was prepared (Scheme 2). 6 In the next steps allylic substituent on 6-N of 5 had to be introduced. To introduce the allylic substituent on 6-N of 5, 9,10-dihydrolysergic acid (2) had to be N-demethylated rst. 2,2,2-Trichloroethyl chloroformate (TrocCl) was used, in a transformation mechanistically analogues to the von Braun reaction, 7 to N-demethylate 9,10-dihydrolysergic acid methyl ester (5). Subsequent zinc mediated reductive cleavage of 6-N-Troc substituted compound 6 gave the desired 6-N-demethylated intermediate 7. This N-demethylation sequence was already reported earlier and slight procedure modications were used in our case. 8 We have noticed that intermediate 7 decomposes slowly in acetic acid and is photolabile and therefore, the reaction yield depends on the swiness of work-up and isolation. 6-NAllylation of 7 was then realized by reaction with allylbromide and potassium carbonate in dimethylformamide, giving allylated intermediate 8 in a high yield (Scheme 3).
9
At this point, intermediate 8 served us for the synthesis of impurities A and D. Alkaline hydrolysis of methyl ester 8 gave cabergolinic acid, termed as impurity A by Ph. Eur., in 82% yield. The impurity D was prepared directly from methyl ester 8 as well. By reacting 8 with 3-(dimethylamino)-1-propylamine in acetic acid, direct amidation of ester gave impurity D in 74% yield (Scheme 4).
4
Compared to A and D, both impurities B and C have an ethylcarbamoyl functionality on the indole nitrogen. Since such functionalization of indole nitrogen requires the use of base, epimerization at the C8 position of ester 8 was possible. Although the stereocenter at C8 in 9,10-dihydrolysergic acid (2) is less prone to epimerization under basic conditions than in lysergic acid, due to the absence of C9-C10 double bond, epimerization does occur. 10, 11 For example, it is known from the literature, that exposing compound 5 to 4 equivalents of NaH in THF at 20 C, app. 30% of the opposite, thermodynamically less favourable, axial epimer is observed, and by exposing compound 8 to 4 equivalents of LDA in THF at À20 C, almost 71% of axial epimer is generated. 11 Therefore, for installing the ethylcarbamoyl fragment on the indole nitrogen N-1 we have envisioned two different approaches. In the rst one, a direct functionalization of N-1 of 8, under basic conditions with EtNCO was planned. Being aware of the potential epimerisation problems under these conditions, a second indirect approach was envisioned. In this, indirect approach it was planned to reduce C8 carbonyl group of 8 to corresponding alcohol, do the functionalization of N-1 with EtNCO under basic conditions and then reoxidise the alcohol back to the corresponding carboxylic acid. Although longer, this reduction/oxidation approach, in comparison to the rst direct one, would ensure us with the epimerisation free preparation of the desired carboxylic acid. Since both approaches for functionalization of N-1, direct and indirect one, have advantages and disadvantages, we have decided to test both of them. Subjecting methyl ester 8 to the 1.1 equivalents of NaH and EtNCO afforded the desired epimer 9a in 6 : 1 diastereomeric ratio and with 47% isolated yield (Scheme 5).
12 With the methyl ester 9a in hand we were only one step short of the key intermediate 9,10-dihydrolysergic acid 10, which would enable us to prepare impurities B and C. Luckily saponication of the methyl ester 9a proceeded selectively with respect to the N-1 ethylcarbamoyl fragment. This has provided us with the desired 9,10-dihydrolysergic acid derivative 10 in 77% yield. We found 9,10-dihydrolysergic acid 10 rather difficult to isolate, since it displays modest solubility in both organic solvents and water, but with acid 10 in hand, the door towards completion of the synthesis plan was open (Scheme 5).
For the indirect approach, methyl ester 8 had to be reduced rst. Reacting ester 8 with the LiAlH 4 in THF proceeded smoothly and in high yield to give 9,10-dihydrolysergol derivative 11. 13 Hydroxy group in 9,10-dihydrolysergol derivative 11 was protected as TBDMS ether 12 and a carbamoyl moiety was introduced by reacting 12 with sodium hydride and ethylisocyanate to give TBDMS-protected 9,10-dihydrolysergol derivative 13 (Scheme 6).
For the next steps, TBDMS-protected alcohol group in 13 had to be removed and free alcohol reoxidized back to carboxylic acid. Deprotection of silyl ether in 13 with TBAF gave 9,10-dihydrolysergol derivative 14 in very good yield, although some temperature dependent chemoselectivity was observed. When silyl deprotection was performed at 0 C, slow but clean conversion of 13 to 14 was achieved. On the other hand, when the reaction was done at room temperature, removal of the ethylcarbamoyl group was observed in addition to silyl deprotection. 9,10-Dihydrolysergol derivative 14 was then used for subsequent oxidation reaction. Ideally a one-step oxidation procedure from primary alcohol 14 to the corresponding carboxylic acid would be a method of choice. But surprisingly, while searching the literature, we learned that examples covering oxidations of 9,10-dihydrolysergols and their derivatives to the corresponding 9,10-dihydrolysergals and/or 9,10-dihydrolysergic acids are very scarce. In the most recent literature, Křen et al. reported on their efforts to oxidize N-1-protected lysergol derivatives to aldehydes and acids. 14 Beside that, patent literature covers two examples of 9,10-dihydrolysergol oxidations. In the rst one BAIB/TEMPO was used for direct oxidation of 9,10-dihydrolysergol derivative to the corresponding 9,10-dihydrolysergic acid. 15 Unfortunately, BAIB/TEMPO mediated oxidation did not work in our case, giving only traces of the desired acid, and failure to oxidize the alcohol 14 is in agreement with the results reported in the literature.
14 In the second literature example, slightly modied Parikh-Doering oxidation (SO 3 $TEA, DMSO, TEA) was successfully used to oxidize 9,10-dihydrolysergol to the 9,10-dihydrolysergal, 16 but as reported by Křen, they were unsuccessful in repeating this type of oxidation under standard Parikh-Doering conditions (SO 3 $Py, DMSO, TEA).
14 Since 9,10-dihidrolysergol derivatives are poorly soluble in various solvents, we anticipated that DMSO mediated oxidations could be a good choice amongst the plethora of alcohol oxidation methods. DMSO should address the solubility issue of 9,10-dihydrolysergol derivative and concurrently serve as an oxidant. Since contrary reports about effectiveness of the Parikh-Doering oxidation of 9,10-dihidrolysergols were available in the literature, we have decided to try other analogues reaction. Luckily one can chose among different DMSO mediated oxidations. Indeed, when alcohol 14 was subjected to Ptzner-Moffatt oxidation conditions, a clean and high yielding conversion to the corresponding 9,10-dihydrolysergal 15 was observed. 17 Here again temperature dependence on reaction selectivity was observed. Below 5 C the reaction was clean, giving only aldehyde as a product, while at room temperature or higher several side products could be observed by TLC. Since we were successful with Ptzner-Moffatt oxidation of 14, the question was raised, whether the outcome of Parikh-Doering reaction, on the same alcohol substrate would be analogues? Oxidation of the alcohol 14, under the Parikh-Doering conditions, proceeded smoothly, affording aldehyde 15 in slightly lower yield than via Ptzner-Moffatt reaction (Scheme 7).
18
An added value of this oxidation transformations also lies in the 9,10-dihydrolysergal itself. Knowing that aldehydes of this type are difficult to prepare and that pharmacological activity of synthetically modied ergot alkaloids varies mainly because of the nature and conguration of substituents on C8, such aldehydes also represent valuable medicinal chemistry intermediates. 4a,16a,19 Oxidations of 9,10-dihydrolysergals to the corresponding 9,10-dihydrolysergic acids are hardly reported in the literature. This is mainly due to the fact that 9,10-dihydrolysergic acid derivatives are easily accessible from naturally occurring lysergic acid. The literature reports on oxidation of 9,10-dihydrolysergal with Tollens's reagent or MCPBA, but both methods have their limitations.
14 The rst one unfortunately gives poor yields while the second one suffers from chemoselectivity. Peroxy acid oxidizes not only the aldehyde, but also the nitrogen on position 6 to the corresponding N-oxide. Although reduction of N-oxide to the desired 9,10-dihydrolysergic acid was demonstrated, 14 this method suffers from functional group compatibility, since allylated lysergal derivatives are not tolerated by peroxy acids nor catalytic hydrogenation. On the other hand there are some examples of lysergal oxidations to lysergic acid derivatives. In the nal steps of total synthesis of lysergic acid by Fujii and Ohno, Pinnick oxidation was used to oxidize 1-N-6-N-ditosylated isolysergal into the corresponding lysergic acid. 20 Indeed, upon subjecting aldehyde 15 to Pinnick oxidation, the desired 9,10-dihydrolysergic acid 10 was obtained, in 69% yield (Scheme 7).
21
9,10-Dihydrolysergic acid 10 was then used to synthesize both impurities B and C. The coupling of 10 with 3-(dimethylamino)-1-propylamine by the use of CDI furnished the impurity B in 54% yield. For the synthesis of impurity C a more complex N-acylurea appendage on C8 had to be installed. In the original synthesis of cabergoline, this side chain was installed with the use of EDC$HCl, by exploiting the usually undesired ability of carbodiimide coupling reagents to form N-acylureas as intramolecular rearrangement side products.
22 Reacting cabergolinic acid A with EDC$HCl, in the absence of an external nucleophile, Mantegani and co-workers synthesized cabergoline (1) .
4 Although the use of EDC$HCl gives the desired N-acylurea appendage in one step, a disadvantage of using this asymmetric carbodiimide is concomitant formation of regioisomeric N-acylurea and tedious separation of both isomers.
To compensate for disadvantage of applying EDC$HCl, different synthetic strategy was utilized in which excess ethylisocyanate was reacted with compound D to install N-acylurea appendage. Unfortunately the use of ethylisocyanate is also the root cause for formation of impurities B and C as side products in cabergoline (1) synthesis (Scheme 1). 4 Other methods for N-acylurea installation in cabergoline (1) synthesis were also developed, although none of them introduces N-acylurea appendage in one step from the corresponding 9,10-dihydrolysergic acid.
23 Therefore, compromising lower yield, we have used EDC$HCl in DCM 24 for the synthesis of impurity C, thus preparing the desired impurity and its regioisomer 16 in ratio 5 : 1 respectively.
25 Aer separation of regioisomers, the impurity C was obtained in 58% yield (Scheme 8).
For the synthesis of C, another synthetic strategy would be viable, by following linear route 10 / B / C. By reacting B with an excess of EtNCO, impurity C could be prepared. In the original synthesis of cabergoline (1) up to 40 equivalents of EtNCO were reacted with compound D to get the desired API. The amount of EtNCO was later reduced in consequent synthesis optimizations, by the use of CuI and Ph 3 P catalysis, to as low as 3 equivalents. Under these, optimised conditions cabergoline (1) was prepared along with the impurities B and C in the ratio of 82 : 6 : 12 respectively. 26 As mentioned earlier, other syntheses of cabergoline (1) were developed to avoid the use of toxic EtNCO and they are all based on the functionalization of the carboxamide side chain of D. 23 In our case the impurity B was prepared from precursor 10 in a modest 54% yield. Therefore, if the reaction of B with EtNCO, or any other suitable reagent, would work quantitatively, the impurity C, starting linearly from 10, would be prepared in not greater than 54% yield. Following this, we have never tried to prepare impurity C from 10 via impurity B. Instead, the impurity C was prepared in one step, directly from carboxylic acid 10 with 58% yield (Scheme 8).
The structure of proper N-acylurea appendage in the impurity C was determined using 2D COSY NMR technique, where expected interactions between ethylamido protons were observed (Fig. 2) . The proton NMR of the impurity C is also in accordance with the previous report of Mantegani and co-workers. (1) was demonstrated and the synthesized impurities are used as HPLC analytical standards. To the best of our knowledge, this is the rst report on selective synthesis of these impurities. From a-ergocryptine (3), 9,10-dihydrolysergic acid methyl ester (5) was prepared, which served as the key starting material. Using 5, N-1 ethylcarbamoyl 9,10-dihydrolysergic acid 10 was prepared via two different routes. First route, a direct one, proceeds through direct N-1 ethylcarbamoylation of 10, causing partial epimerisation at C8 position. In spite of epimerisation, this route is shorter and therefore advantageous over the indirect one. Second route, an indirect one, follows reduction-oxidation of 9,10-dihydrolysergic acid derivative 8, for epimerisation free installation of N-1 ethylcarbamoyl moiety. Notwithstanding the fact that oxidations of 9,10-dihydrolysergol derivatives to the corresponding 9,10-dihydrolysergals and further on to 9,10-dihydrolysergic acids are very rare, we have shown that by combination of activated DMSO and Pinnick reactions this oxidation sequence can be achieved successfully. Furthermore, such oxidation method of preparing otherwise scarcely presented 9,10-dihydrolysergals, can be useful in medicinal chemistry, for preparing novel pharmacologically active C8-substituted derivatives of ergoline.
Experimental

General experimental details
Where stated, anhydrous reactions were carried out in vacuum oven dried glassware, under stream of nitrogen, passed through DrieriteÔ drying column. Anhydrous solvents were purchased form Sigma-Aldrich and all reagents were commercial grade, used without any purication. Exception was a-ergocryptine which was acquired through in-house biofermentation process and was puried by crystallization from toluene. Reactions were monitored by thin layer chromatography (TLC) performed on pre-coated aluminum-baked silica gel (60 F 254 9,10-Dihydro-a-ergocryptine (4). In a 1000 mL round-bottom ask a-ergocryptine (3) was weighed (30 g, 52 mmol) and dissolved in MeOH (500 mL) at 35 C. Then, while stirring, Pd (3.9 g, 10% on carbon) suspended in MeOH (143 mL) was added and reaction mixture was purged with N 2 . Aer that reaction (2) . To NaOH (8.28 g, 207 mmol) in 250 mL ask, H 2 O (96 mL) and Na 2 S 2 O 4 (1.2 g, 6.89 mmol) were added and solution was formed at room temperature. While stirring, 9,10-dihydro-a-ergocryptine (4) (20 g, 34.6 mmol) was suspended in the solution and reaction mixture was reuxed for 4 h. Aer that, dark brown solution was cooled to room temperature and acidied with AcOH to pH 6.2. Suspension formed was cooled bellow 15 C and stirred for 2 h. 3- fg]quinoline-9-carboxylate (7). Compound 6 (20 g, 44.9 mmol) was suspended in AcOH (885 mL) and MeOH (140 mL) was added. Suspension was stirred vigorously at room temperature and Zn (20 g, 306 mmol) was added. Aer 65 min Zn was ltered off and ltrate was concentrated under reduced pressure. To the residue on concentration H 2 O (500 mL) was added, suspension was stirred for 0.5 h and ltered. Filtrate was then basied with saturated aqueous NH 4 OH to pH 8.1, DCM (400 mL) was added and suspension was then acidied with glacial AcOH back to pH 6.6. Phases were separated and water phase was again basied with saturated aqueous NH 4 OH to pH 8.1, DCM (200 mL) was added and pH was adjusted back to pH 6.6 with glacial AcOH. Phases were separated and combined organic phases were dried over MgSO 4 , concentrated under reduced pressure to give white solid that was suspended in heptane (225 mL), stirred for 1 h and ltered. White solid was washed with heptane and dried to give titled compound (8.6 g, 71%). (6aR,9R,10aR)-7-Allyl-N-[3-(dimethylamino)propyl]-4,6,-6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide D. Compound 8 (0.500 g, 1.6 mmol) was dissolved in 3-dimethylamino-1-propylamine (3 mL) and glacial acetic acid was added (0.1 mL) and was stirred for 24 h at reux temperature. Then the reaction mixture was cooled to room temperature and concentrated under reduced pressure to an oily brown residue. To the residue, EtOAc (100 mL) was added and organic phase was washed with 10% aqueous NaHCO 3 (30 mL) and phases were separated. Aqueous phase was reextracted with EtOAc (2 Â 75 mL) and combined organic phases were washed with brine (2 Â 50 mL). Organic phase was dried over anhydrous MgSO 4 , concentrated under reduced pressure and residue was crystallized from acetone to give titled compound as a light yellowish solid (450 mg, 74%). (6aR,9R,10aR )-Methyl 7-allyl-4-(ethylcarbamoyl)-4,6,6a,7,8,9,-10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate (9a). Compound 8 (0.6 g, 1.90 mmol) in an oven dried round-bottom ask was dissolved in anhydrous THF (16 mL) under N 2 atmosphere and cooled to $3 C (ice/water bath). To the solution NaH (83.6 mg, 60% in mineral oil, 2.1 mmol) was added. Mixture was stirred for additional 10 min and EtNCO (0.225 mL, 2.8 mmol) was added. Reaction mixture was warmed to room temperature and stirred for 3 h. Aer 3 h reaction mixture was cooled to $3 C and quenched with brine (1 mL). Suspension was concentrated under reduced pressure and residue was suspended in DCM (100 mL). Water (75 mL) was added and phases were separated. Water phase was reextracted with ethyl acetate (40 mL) and combined organic phases were dried over MgSO 4 and concentrated in vacuum. 12 Residue on evaporation was puried using column chromatography to give title compound as a white solid (0.341 g, 47%). , 1H); 1.32-1.42 (m, 1H); 2.28-2.36 (m, 2H) 15.0, 25.7, 30.3, 34.9, 40.6, 51.6, 54.3,  55.4, 62.8, 112.9, 115.1, 115.9, 117.9, 118.1, 124.7, 127.1, 132.8 (6aR,9R,10aR)-7-Allyl-4-(ethylcarbamoyl)-4,6,6a,7,8,9 ,10,10a-octahydroindolo[4,3-fg]quinolone-9-carboxylic acid (10) (a) Via saponication of 9a. In a round-bottom ask compound 9a (100 mg, 0.272 mmol) was dissolved in THF-H 2 O mixture (2 : 1, 6 mL). To the mixture aqueous solution of NaOH (1.0 M, 0.6 mL) was added and reaction mixture was stirred for 1 h. Aer that aqueous HCl (1.0 M, 0.9 mL) was added reaction mixture was concentrated under reduced pressure. The residue on evaporation was puried by column chromatography (THF-H 2 O-AcOH ¼ 98 : 1 : 1) to give titled compound as a yellowish solid (76.9 mg, 77%).
(b) Via Pinnic oxidation of 15. To aldehyde 15 (1.84 g, 5.20 mmol), t-BuOH (18 mL) and THF (18 mL) were added and solution was stirred and cooled to $3 C (ice/water bath). Then 2-methyl-2-butene (2.83 mL, 26.86 mmol) was added. To this a solution of NaH 2 PO 4 (1.89 g, 15.7 mmol) and NaClO 2 (1.42 g, 12.6 mmol, 80%) in H 2 O (18 mL) was added slowly. Reaction mixture was stirred for 1.5 h at $3 C (ice/water bath) and then it was stopped with addition of Na 2 SO 3 (2.02 g, 16.0 mmol). Precipitate formed was ltered off and ltrate was concentrated under reduced pressure. Residue on concentration was puried by column chromatography with two different mobile phases used sequentially. First mobile phase (DCM-MeOH ¼ 10 : 1) was used to separate yellow impurities and second mobile phase (THF-H 2 O-AcOH ¼ 98 : 1 : 1) was used to elute product which upon evaporation and drying gave light yellowish solid (1.33 g, 68% (12) . To alcohol 11 (6.00 g, 21.2 mmol) in DMF (150 mL), imidazole (4.34 g, 63.8 mmol) and TBDMS-Cl (4.80 g, 31.9 mmol) were added. Reaction mixture was stirred for 2 h at room temperature aer which it was quenched with saturated, aqueous solution of NaHCO 3 (150 mL). To a white suspension, H 2 O (500 mL) and EtOAc (400 mL) were added and phases were separated aer addition of brine (30 mL). Water phase was washed with EtOAc (2 Â 300 mL). Combined organic phases were reextracted with water (3 Â 400 mL), dried over anhydrous Na 2 and NaH (1.86 g, 60% in mineral oil, 44.4 mmol) was added.
Suspension was stirred for additional 10 min at indicated temperature and EtNCO (4.80 mL, 60.6 mmol) was added. Reaction mixture was then warmed to room temperature and stirred for 3 h. Aer 3 h reaction mixture was cooled to $3 C and quenched with brine (20.4 mL (6aR,9R,10aR)-7-Allyl-N-ethyl-9-formyl-6a,7,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4(6H)-carboxamide (15). 17, 18 (a) Via Ptzner-Moffatt oxidation of 14. Alcohol 14 (3.00 g, 8.49 mmol) was dissolved in anhydrous DMSO (20 mL) and anhydrous DCM (20 mL) under N 2 atmosphere. Solution was cooled to $3 C (ice/water bath) and with stirring DCC (5.26 g, 25.5 mmol), anhydrous pyridine (1.38 mL, 17 mmol) and TFA (0.99 mL, 12.7 mmol) were added sequentially. Reaction mixture was stirred for 1.5 h at $3 C (ice/water bath).
Suspension formed was ltered and to the ltrate DCM (250 mL) was added and organic phase was washed with water (3 Â 250 mL). Combined water phases were reextracted with DCM (250 mL). Then combined organic phases were dried over anhydrous Na 2 SO 4 , concentrated under reduced pressure and residue was puried by column chromatography (MeOH-EtOAc ¼ 10 : 90 and DCM-MeOH ¼ 90 : 10) to give titled aldehyde as a white solid (2.60 g, 87%).
(b) Via Parikh-Doering oxidation of 14. In an oven dried, round-bottom ask, alcohol 14 (50 mg, 0.141 mmol) under N 2 atmosphere, was dissolved in anhydrous DMSO (2 mL) and to the solution anhydrous DCM (2 mL) was added. Et 3 N (0.197 mL, 1.41 mmol) was added and reaction mixture was cooled to $3 C (ice/water bath). To this solution SO 3 $Py (67.4 mg, 0.423 mmol) dissolved in anhydrous DMSO (0.25 mL) was added dropwise and reaction mixture was stirred for 80 min. Aer that time reaction mixture was poured in to H 2 O (20 mL) and water phase was extracted with DCM (3 Â 15 mL). Combined organic phases were dried over MgSO 4 and concentrated under reduced pressure. Residue on concentration was puried by column chromatography (EtOH-EtOAc ¼ 1 : 9) to give aldehyde 15 as a white solid (33.7 mg, 68%). 
